KS SB 330
deadEnacting the ensuring transparency in prior authorization act to impose requirements and limitations on the use of prior authorization in healthcare.
Kansas · 2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did KS SB 330 pass?
No. KS SB 330 did not pass — it was defeated or died in the legislative process. Latest recorded action (2026-04-10): Died in Committee
What is KS SB 330 about?
KS SB 330 is a bill in the 2026 Regular Session titled “Enacting the ensuring transparency in prior authorization act to impose requirements and limitations on the use of prior authorization in healthcare.”.
Who sponsors KS SB 330?
Committee on Financial Institutions and Insurance is the primary sponsor of KS SB 330.
- Introduced
- 2026-01-14
- Latest action
- 2026-04-10 — Died in Committee
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Committee on Financial Institutions and Insuranceprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-04-10
Died in Committee
failure
2026-01-15
Referred to Senate Committee on Financial Institutions and Insurance
referral-committee
2026-01-14
Introduced
introduction
Versions
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T04:56:44.586501Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=KS&identifier=SB 330. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.